On January 2, 2026, the US Food and Drug Administration (FDA) began accepting statements of interest…
Continue ReadingTag: TEMPO
Use of digital health devices before authorization under the TEMPO pilot
The U.S. Food and Drug Administration (FDA) announced the Technology-Enabled Meaningful Patient Outcomes for Digital Health…
Continue Reading
ACCESS + TEMPO: The 2-door entryway to faster digital health innovation in traditional Medicare | McDermott+
McDermott+ is pleased to bring you Regs & Eggs, a weekly Regulatory Affairs blog by Jeffrey…
Continue Reading